-
Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Consensus Recommendation of "Buy" from Brokerages
ソース: Buzz FX / 31 1 2025 03:41:10 America/New_York
Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Consensus Recommendation of "Buy" from Brokerages Written by MarketBeat January 31, 2025 Share Link copied to clipboard. Shares of Stoke Therapeutics, Inc.
Read more...